Lipid-lowering drugs as primary prevention in general practice: Do patients reach guideline goals and continue treatment? ADDITION Denmark

By Graversen Lise   Christensen Bo   Borch-Johnsen Knut   Lauritzen Torsten   Sandbaek Annelli  

Scandinavian Journal of Primary Health Care, Vol. 29, Iss. 4, 2011-12 ,pp. : 216-221

Informa Healthcare

Access to resources Recommend Favorite

Lipid-Lowering Drugs: Are Adverse Effects Predictable and Reversible?

By  

Cardiology, Vol. 97, Iss. 3, 2002-06 ,pp. : 115-121

Karger

Access to resources Recommend Favorite

Do Lipid Lowering Drugs Reduce the Risk of Coronary Heart Disease?

By Pritzker L. B.  

Critical Reviews in Clinical Laboratory Sciences, Vol. 35, Iss. 6, 1998-12 ,pp. : 603-621

Informa Healthcare

Access to resources Recommend Favorite

Cancer mortality according to lipid-lowering drugs and lipoproteins in a general population

By Bérard E.   Bongard V.   Dallongeville J.   Arveiler D.   Ruidavets J.B.   Ferrières J.  

Current Medical Research and Opinion, Vol. 27, Iss. 10, 2011-10 ,pp. : 1963-1971

Informa Healthcare

Access to resources Recommend Favorite

Rapid effects of different lipid-lowering drugs on PCSK9 in humans

By Liu Jun   Guo Yuan-Lin   Xu Rui-Xia   Li Jian-Jun  

Clinical Lipidology, Vol. 8, Iss. 5, 2013-10 ,pp. : 519-524

Future Medicine

Access to resources Recommend Favorite